MetaCap

Cellectar Biosciences (CLRB) News

NASDAQ: CLRBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.797-0.1036 (-11.50%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CLRB news summary

We found 4 recent headlines mentioning Cellectar Biosciences (CLRB): 0 in the past week and 3 in the past 30 days, most often from GlobeNewswire, Nasdaq. CLRB is making an outsized move today, down 11.50% at $0.797, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Cellectar Biosciences Q3 Loss Widens; Eyes FDA Filing For Iopofosine I-131 In H1 2027", was published by Nasdaq on Nov 11, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Cellectar Biosciences headlines

Stocks mentioned alongside CLRB

Compare CLRB